Literature DB >> 2881125

In-vitro chloroquine and mefloquine-resistant Plasmodium falciparum in Nigeria.

L A Salako, A Fadeke Aderounmu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881125     DOI: 10.1016/s0140-6736(87)90221-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Malaria and its prevention in British residents visiting west Africa.

Authors:  P A Phillips-Howard; D J Bradley; D Waghorn
Journal:  J R Coll Gen Pract       Date:  1988-05

2.  Combating severe malaria in African children.

Authors:  J G Breman; C C Campbell
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

3.  Disposition of quinine in plasma, red blood cells and saliva after oral and intravenous administration to healthy adult Africans.

Authors:  L A Salako; A Sowunmi
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Nigerian children.

Authors:  O J Ekanem; J S Weisfeld; L A Salako; B L Nahlen; E N Ezedinachi; O Walker; J G Breman; O J Laoye; K Hedberg
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

5.  Pharmacokinetics of quinine in African patients with acute falciparum malaria.

Authors:  C P Babalola; O O Bolaji; F A Ogunbona; A Sowunmi; O Walker
Journal:  Pharm World Sci       Date:  1998-06

6.  Curative and preventive treatment of uncomplicated malaria in public health institutions in Cameroon.

Authors:  P M Ndumbe
Journal:  Eur J Epidemiol       Date:  1989-06       Impact factor: 8.082

7.  Efficacy, safety and tolerability of artesunate-mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria.

Authors:  Philip U Agomo; Martin M Meremikwu; Ismaila M Watila; Innocent J Omalu; Friday A Odey; Stephen Oguche; Valentine I Ezeiru; Olugbenga O Aina
Journal:  Malar J       Date:  2008-09-09       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.